Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.26 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (parietal cells) | 0.10 |
| chemistry Open Targets | compounds already reach it: tegoprazan, pantoprazole, pantoprazole sodium +14 | 1.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 1626
Sealed predictions
- ATP4B in dopamine neurons, braak+0.02 (p 0.964) → -0.32 (p 0.407)receipt 1633
Swarm cases
receipt 1633: ATP4B in dopamine neurons, braak
- power
- full sample -0.18 (p 0.465, n 18), 95% CI -0.60 to +0.31. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.18 (p 0.465, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.10 (p 0.690, n 18). could be the mix.
- skeptic
- leave-one-out range -0.31 to -0.08, sign flips 0; without severely affected donors -0.18 (p 0.465, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ATP4B in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts